Impact of COVID-19 on heart failure hospitalization and outcome in India – A cardiological society of India study (CSI-HF in COVID 19 times study – “The COVID C-HF study”).

Publication date: Aug 29, 2023

The presentation and outcomes of acute decompensated heart failure (ADHF) during COVID times (June 2020 to Dec 2020) were compared with the historical control during the same period in 2019. Data of 4806 consecutive patients of acute HF admitted in 22 centres in the country were collected during this period. The admission patterns, aetiology, outcomes, prescription of guideline-directed medical therapy (GDMT) and interventions were analysed in this retrospective study. Admissions for acute heart failure during the pandemic period in 2020 decreased by 20% compared to the corresponding six-month period in 2019, with numbers dropping from 2675 to 2131. However, no difference in the epidemiology was seen. The mean age of presentation in 2019 was 61. 75 (+/-13. 7) years, and 59. 97 (+/-14. 6) years in 2020. There was a significant decrease in the mean age of presentation (p = 0. 001). Also. the proportion of male patients decreased significantly from 68. 67% to 65. 84% (p = 0. 037). The in-hospital mortality for acute heart failure did not differ significantly between 2019 and 2020 (4. 19% and 4. ,97%) respectively (p = 0. 19). The proportion of patients with HFrEF did not change in 2020 compared to 2019 (76. 82% vs 75. 74%, respectively). The average duration of hospital stay was 6. 5 days. The outcomes of ADHF patients admitted during the Covid pandemic did not differ significantly. The length of hospital stay remained the same. The study highlighted the sub-optimal use of GDMT, though slightly improving over the last few years.

Concepts Keywords
Covid Acute heart failure
Decreased COVID-19


Type Source Name
disease MESH COVID-19
disease MESH heart failure
disease IDO country

Original Article

(Visited 1 times, 1 visits today)